IRVINE, Calif., April 19, 2016 -- Sabra Health Care REIT, Inc. (NASDAQ:SBRA) (NASDAQ:SBRAP) announced today that it will issue its 2016 first quarter earnings release after close of market on May 2, 2016.
A conference call with a simultaneous webcast to discuss the 2016 first quarter earnings will be held on Tuesday, May 3 at 10:00 a.m. Pacific Time. The dial in number for the conference call is 888-395-3227 and the participant code is SABRA.
The webcast URL is https://www.webcaster4.com/Webcast/Page/1456/14710.
A replay of the call will also be available for 30 days following the call, by dialing 888-203-1112 and using the passcode 2152940.
ABOUT SABRA
Sabra Health Care REIT, Inc. (Nasdaq:SBRA), a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. Sabra leases properties to tenants and operators throughout the United States and Canada.
Contact: Investor & Media Inquiries: (949) 679-0410


7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Italy Fines Apple €98.6 Million Over App Store Dominance
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 



